The impact of MRI-lesion targeted (TB) and systematic biopsy (SB) Gleason score (GS) as a predictor for final pathological GS still remains unclear.
All patients with TB + SB, and subsequent radical prostatectomy (RP) between 01/2014-12/2020 were analyzed.